July 6, 2020
CADTH is proud to welcome Suzanne McGurn, who begins her role as President and Chief Executive Officer today.
Ms. McGurn was appointed by the CADTH Board of Directors after a comprehensive search that was international in scope. She brings to CADTH significant leadership experience and a deep…
June 26, 2020
See Pharmaceutical Reviews Update – Issue 16 for important news and information related to CADTH’s drug review programs. Highlights from this issue include:
a consultation on CADTH’s drug reimbursement review procedures
a consultation on the Health Canada, CADTH, and INESSS aligned review…
June 22, 2020
Canadian policy-makers face challenges with the number of drugs for rare indications and rapidly rising costs. In facing these challenges, decision-makers see real-world evidence (RWE) as an opportunity.
Health Canada and CADTH recently announced the intent to co-develop an action plan to optimize…
June 8, 2020
On March 24, Dr. Maurice McGregor turned 100.
Dr. McGregor is affectionately known as the “grandfather of health technology assessment” in Canada. In 2014 CADTH acknowledged his enduring legacy and his immeasurable contributions to Canadian health care by establishing an award in his name. This…
May 28, 2020
A new project on Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Cancer is now available for feedback from all interested stakeholders.
Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Cancer
Call for Feedback: 2020-05-22
Feedback Due By:…